Adult Attention Deficit/Hyperactivity Disorder, Associated Symptoms and Comorbid Psychiatric Disorders: Diagnosis and Pharmacological Treatment

被引:3
|
作者
Paslakis, G. [1 ]
Schredl, M. [1 ]
Alm, B. [1 ]
Sobanski, E. [1 ]
机构
[1] Heidelberg Univ, Klin Psychiat & Psychotherapie, Med Fak Mannheim, Zentralinst Seel Gesundheit, D-68159 Mannheim, Germany
关键词
adult ADHD; depression; substance abuse disorder; anxiety disorder; sleep disorder; DEFICIT-HYPERACTIVITY DISORDER; DOUBLE-BLIND; CONTROLLED-TRIAL; DUAL DIAGNOSIS; SLEEP QUALITY; METHYLPHENIDATE; ADHD; STIMULANTS; COCAINE; PREVALENCE;
D O I
10.1055/s-0033-1335657
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Adult attention deficit/hyperactivity disorder (ADHD) is characterised by inattention and/or hyperactivity and impulsivity and is a frequent psychiatric disorder with childhood onset. In addition to core symptoms, patients often experience associated symptoms like emotional dysregulation or low self-esteem and suffer from comorbid disorders, particularly depressive episodes, substance abuse, anxiety or sleep disorders. It is recommended to include associated symptoms and comorbid psychiatric disorders in the diagnostic set-up and in the treatment plan. Comorbid psychiatric disorders should be addressed with disorder-specific therapies while associated symptoms also often improve with treatment of the ADHD core symptoms. The most impairing psychiatric disorder should be treated first. This review presents recommendations for differential diagnosis and treatment of adult ADHD with associated symptoms and comorbid psychiatric disorders with respect to internationally published guidelines, clinical trials and expert opinions.
引用
收藏
页码:444 / 451
页数:8
相关论文
共 50 条
  • [41] Pharmacotherapy of Attention-Deficit/Hyperactivity disorder (ADHD) and comorbid disorders
    Wiesegger, Georg
    Kienbacher, Christian
    Pellegrini, Elisabeth
    Scheidinger, Hans
    Vesely, Christine
    Und, Waltraud BangerJ
    Friedrich, Max
    NEUROPSYCHIATRIE, 2007, 21 (03) : 187 - 206
  • [42] Diagnosis and treatment of patients with comorbid substance use disorder and adult attention-deficit and hyperactivity disorder: a review of recent publications
    van der Burg, Duco
    Crunelle, Cleo L.
    Matthys, Frieda
    van den Brink, Wim
    CURRENT OPINION IN PSYCHIATRY, 2019, 32 (04) : 300 - 306
  • [43] Making a diagnosis of adult attention deficit hyperactivity disorder
    Hutchinson, G
    WEST INDIAN MEDICAL JOURNAL, 2002, 51 (03): : 174 - 175
  • [44] Performance on Executive Functions and Comorbid Associated Symptoms in Children with Attention Deficit Hyperactivity Disorder (ADHD)
    Rubiales, Josefina
    Bakker, Liliana
    Russo, Daiana
    Gonzalez, Rocio
    REVISTA CES PSICOLOGIA, 2016, 9 (02): : 99 - 113
  • [45] Inattention symptoms and the diagnosis of comorbid attention-deficit/hyperactivity disorder among youth with generalized anxiety disorder
    Elkins, R. Meredith
    Carpenter, Aubrey L.
    Pincus, Donna B.
    Comer, Jonathan S.
    JOURNAL OF ANXIETY DISORDERS, 2014, 28 (08) : 754 - 760
  • [46] International Consensus on the screening, diagnosis and treatment of patients with substance use disorders comorbid with attention deficit disorder with or without hyperactivity
    van Kernebeek, Michiel W.
    Vorspan, Florence
    Crunelle, Cleo L.
    van den Brink, Wim
    Dom, Geert
    Moggi, Franz
    Konstenius, Maija
    Franck, Johan
    Levin, Frances R.
    van de Glind, Geurt
    Ramos-Quiroga, Jose A.
    Demetrovics, Zsolt
    Coetzee, Corne
    Luderer, Mathias
    Schellekens, Arnt
    Matthys, Frieda
    Icick, Romain
    TOXICOLOGIE ANALYTIQUE ET CLINIQUE, 2022, 34 (02) : 55 - 67
  • [47] Adult attention deficit hyperactivity disorder is associated with asthma
    Ole Bernt Fasmer
    Anne Halmøy
    Tomas Mikal Eagan
    Ketil Joachim Oedegaard
    Jan Haavik
    BMC Psychiatry, 11
  • [48] Adult attention deficit hyperactivity disorder is associated with asthma
    Fasmer, Ole Bernt
    Halmoy, Anne
    Eagan, Tomas Mikal
    Oedegaard, Ketil Joachim
    Haavik, Jan
    BMC PSYCHIATRY, 2011, 11
  • [49] Pharmacological Treatment and Demographic Characteristics of Adult Patients with Attention Deficit Hyperactivity Disorder, Sweden
    Bahmanyar, Shahram
    Kieler, Helle
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 424 - 424
  • [50] LEGAL PROBLEMS IN PATIENTS WITH COMORBID ADULT ATTENTION-DEFICIT HYPERACTIVITY DISORDER AND SUBSTANCE USE DISORDERS
    Abdelkarim, A.
    Salama, H.
    Latif, S. Abdel
    El Magd, O. Abou
    EUROPEAN PSYCHIATRY, 2014, 29